Mar-31-20 Upgrade
CJS Securities
Market Perform → Market Outperform
Mar-18-20 Upgrade
KeyBanc Capital Markets
Sector Weight → Overweight
$206
Aug-08-19 Downgrade
Raymond James
Strong Buy → Outperform
Oct-17-17 Initiated
KeyBanc Capital Mkts
Sector Weight
Jun-20-17 Downgrade
Sidoti
Buy → Neutral
Mar-11-16 Initiated
Gabelli & Co
Buy
$128
Nov-06-15 Reiterated
ROTH Capital
Buy
$124 → $130
Aug-11-15 Reiterated
ROTH Capital
Buy
$102 → $124
May-06-15 Reiterated
ROTH Capital
Buy
$96 → $102
Feb-10-15 Reiterated
ROTH Capital
Buy
$82 → $96
Nov-11-14 Upgrade
ROTH Capital
Neutral → Buy
$56 → $82
May-09-13 Downgrade
The Benchmark Company
Buy → Hold
Sep-27-12 Reiterated
The Benchmark Company
Buy
$60 → $69
Apr-12-12 Initiated
The Benchmark Company
Buy
$60
Sep-26-11 Reiterated
Ticonderoga
Buy
$52 → $49
Oct-29-09 Initiated
C.K. Cooper
Buy
$45
Oct-08-09 Initiated
Roth Capital
Hold
$40
Mar-05-09 Initiated
Northland Securities
Outperform
May-02-08 Initiated
Jesup & Lamont
Buy
$35
Mar-26-08 Initiated
Soleil
Buy
Feb-24-21 08:30AM
Feb-18-21 04:00AM
Feb-04-21 08:00AM
Feb-02-21 08:15AM
Jan-13-21 02:23AM
Jan-05-21 07:30AM
Dec-22-20 10:21AM
Dec-20-20 05:30PM
Dec-08-20 02:10AM
Nov-08-20 08:13AM
Nov-06-20 02:01AM
Nov-05-20 07:20PM
04:05PM
02:30PM
Nov-02-20 09:44AM
Oct-15-20 07:30AM
Oct-07-20 08:51AM
Sep-14-20 10:53PM
Sep-11-20 09:36AM
Sep-08-20 07:30AM
Aug-19-20 01:15PM
Aug-12-20 08:30AM
Aug-10-20 09:00PM
04:05PM
04:00PM
Aug-07-20 08:46AM
Aug-03-20 12:31PM
Jul-27-20 11:23AM
Jul-20-20 12:14PM
Jul-15-20 07:30AM
Jun-17-20 11:35AM
Jun-16-20 04:18PM
Jun-15-20 09:31AM
Jun-10-20 01:21PM
Jun-08-20 05:56PM
12:53PM Thomson Reuters StreetEvents
Jun-05-20 08:44AM
Jun-04-20 11:18AM
Jun-03-20 04:21PM
Jun-02-20 03:05PM
May-28-20 04:53PM
03:58PM
01:40PM
May-27-20 07:25PM
06:30PM
08:18AM
May-25-20 03:00PM
May-22-20 06:24PM
May-21-20 04:20PM
May-20-20 01:19PM
May-19-20 07:00PM
05:00PM
02:54PM
May-15-20 03:49PM
11:42AM
May-14-20 02:45PM
May-08-20 02:30PM
12:17PM
04:46AM
May-07-20 04:05PM
Apr-30-20 12:33PM
Apr-20-20 09:14AM
07:30AM
Apr-09-20 08:27AM
Apr-02-20 01:00PM
Apr-01-20 09:27AM
Mar-27-20 02:53PM
Mar-19-20 08:11AM Thomson Reuters StreetEvents
Mar-06-20 10:18AM
Mar-04-20 09:53AM
Feb-28-20 11:45AM
Feb-27-20 07:25PM
04:05PM
Feb-20-20 12:31PM
Feb-13-20 08:54AM
Feb-06-20 07:30AM
Feb-04-20 04:23AM
Jan-18-20 09:15AM
Jan-07-20 04:05PM
Dec-23-19 08:54AM
Dec-12-19 01:43PM
Dec-06-19 02:26PM
Dec-02-19 04:14PM Thomson Reuters StreetEvents
Nov-27-19 07:18AM
Nov-11-19 05:25PM
04:05PM
Nov-05-19 08:03AM American City Business Journals
Nov-04-19 10:30AM
07:00AM
Oct-30-19 02:00PM
Oct-28-19 11:01AM
Oct-22-19 07:30AM
Oct-14-19 08:16PM
Oct-08-19 08:06AM
Oct-07-19 04:15PM
Sep-18-19 09:05AM
Sep-13-19 05:54PM Thomson Reuters StreetEvents
Sep-09-19 07:00AM
Aug-30-19 10:31AM
Aug-29-19 10:06AM
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in vascular therapy and critical care applications worldwide. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency connectors; SwabCap disinfecting caps; Tego hemodialysis connectors; NovaCath and SuperCath peripheral intravenous (IV) catheters; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, including sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation, such as sodium chloride irrigation, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. In addition, the company offers infusion pumps under the Plum 360 and LifeCare PCA brands; Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. Further, it provides ICU Medical Mednet, an enterprise medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms, as well as related professional services. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Voigtlander Christian B. Chief Operating Officer Feb 18 Option Exercise 0.00 3,519 0 10,949 Feb 19 05:36 PM Jain Vivek Chairman and CEO Feb 18 Option Exercise 0.00 8,044 0 14,285 Feb 19 05:31 PM Woolson Daniel VP, GM-Infusion Capital Feb 18 Option Exercise 0.00 804 0 6,944 Feb 19 05:27 PM Sanzone Virginia Ruth VP, General Counsel Feb 18 Option Exercise 0.00 1,005 0 2,502 Feb 19 05:15 PM SWINNEY ROBERT S Director Feb 02 Option Exercise 43.12 1,500 64,680 24,005 Feb 02 05:01 PM Jain Vivek Chairman and CEO Jan 08 Option Exercise 58.79 38,591 2,268,765 104,832 Jan 08 05:11 PM Jain Vivek Chairman and CEO Jan 08 Sale 220.00 38,591 8,490,020 66,241 Jan 08 05:11 PM Jain Vivek Chairman and CEO Jan 07 Option Exercise 58.79 6,070 356,855 72,311 Jan 08 05:11 PM Jain Vivek Chairman and CEO Jan 07 Sale 220.00 6,070 1,335,400 66,241 Jan 08 05:11 PM Jain Vivek Chairman and CEO Jan 06 Option Exercise 58.79 24,339 1,430,890 90,580 Jan 08 05:11 PM Jain Vivek Chairman and CEO Jan 06 Sale 220.00 24,339 5,354,580 66,241 Jan 08 05:11 PM Jain Vivek Chairman and CEO Jan 04 Option Exercise 58.79 11,500 676,085 77,741 Jan 06 04:15 PM Jain Vivek Chairman and CEO Jan 04 Sale 212.35 11,500 2,442,012 66,241 Jan 06 04:15 PM Jain Vivek Chairman and CEO Dec 04 Option Exercise 58.79 9,200 540,868 75,441 Dec 07 06:06 PM Jain Vivek Chairman and CEO Dec 04 Sale 195.00 9,200 1,794,000 66,241 Dec 07 06:06 PM Jain Vivek Chairman and CEO Dec 03 Option Exercise 58.79 2,300 135,217 68,541 Dec 07 06:06 PM Jain Vivek Chairman and CEO Dec 03 Sale 195.00 2,300 448,500 66,241 Dec 07 06:06 PM LOPEZ GEORGE A Director Nov 12 Sale 194.80 17,000 3,311,546 240,314 Nov 12 05:27 PM LOPEZ GEORGE A Director Nov 11 Sale 194.10 23,000 4,464,324 240,314 Nov 12 05:27 PM Jain Vivek Chairman and CEO Nov 06 Option Exercise 58.79 11,500 676,085 77,741 Nov 10 05:09 PM Jain Vivek Chairman and CEO Nov 06 Sale 195.00 11,500 2,242,500 66,241 Nov 10 05:09 PM SWINNEY ROBERT S Director Oct 16 Option Exercise 36.60 1,500 54,900 22,782 Oct 16 05:05 PM SWINNEY ROBERT S Director Oct 16 Sale 202.22 277 56,015 22,505 Oct 16 05:05 PM Jain Vivek Chairman and CEO Oct 09 Option Exercise 58.79 11,500 676,085 77,741 Oct 13 04:04 PM Jain Vivek Chairman and CEO Oct 09 Sale 195.00 11,500 2,242,500 66,241 Oct 13 04:04 PM McGrody Kevin J Chief Accounting Officer Sep 01 Option Exercise 0.00 572 0 2,632 Sep 02 12:18 PM Jain Vivek Chairman and CEO Sep 01 Option Exercise 58.79 11,500 676,085 77,681 Sep 03 04:45 PM Jain Vivek Chairman and CEO Sep 01 Sale 197.17 11,500 2,267,487 66,181 Sep 03 04:45 PM Jain Vivek Chairman and CEO Aug 27 Option Exercise 58.79 11,500 676,085 77,681 Aug 28 05:27 PM Jain Vivek Chairman and CEO Aug 27 Sale 195.00 11,500 2,242,500 66,181 Aug 28 05:27 PM Bonnell Brian Michael Chief Financial Officer Aug 14 Option Exercise 0.00 1,208 0 1,553 Aug 14 06:11 PM FINNEY ELISHA W Director Aug 13 Sale 190.00 790 150,100 1,483 Aug 13 05:18 PM SWINNEY ROBERT S Director Jul 16 Option Exercise 37.00 1,500 55,500 21,582 Jul 16 05:40 PM SWINNEY ROBERT S Director Jul 16 Sale 188.46 300 56,538 21,282 Jul 16 05:40 PM LOPEZ GEORGE A Director Jun 09 Sale 194.89 8,800 1,715,010 339,764 Jun 10 06:24 PM LOPEZ GEORGE A Director Jun 08 Sale 203.11 1,200 243,736 339,764 Jun 10 06:24 PM LOPEZ GEORGE A Director Jun 03 Sale 199.00 9,331 1,856,869 339,764 Jun 04 07:38 PM LOPEZ GEORGE A Director Jun 02 Sale 200.29 4,118 824,796 339,764 Jun 04 07:38 PM Jain Vivek Chairman and CEO Jun 01 Sale 203.87 15,000 3,058,052 66,211 Jun 03 04:59 PM LOPEZ GEORGE A Director May 28 Sale 197.37 16,551 3,266,738 329,651 Jun 01 04:51 PM FINNEY ELISHA W Director May 13 Option Exercise 0.00 378 0 2,273 May 14 03:50 PM Abbey Donald Director May 13 Option Exercise 0.00 378 0 693 May 14 12:54 PM Hoffmeister David F Director May 13 Option Exercise 0.00 378 0 693 May 14 03:59 PM Greenberg David C. Director May 13 Option Exercise 0.00 378 0 2,703 May 14 12:25 PM SWINNEY ROBERT S Director May 13 Option Exercise 0.00 378 0 20,082 May 14 12:18 PM SWINNEY ROBERT S Director Apr 06 Sale 207.15 1,500 310,725 19,704 Apr 06 05:13 PM Woolson Daniel VP, GM-Infusion Capital Mar 27 Option Exercise 0.00 243 0 6,247 Mar 30 11:43 AM Voigtlander Christian B. Chief Operating Officer Mar 27 Option Exercise 0.00 593 0 8,154 Mar 30 11:39 AM Sanzone Virginia Ruth VP, General Counsel Mar 27 Option Exercise 0.00 593 0 1,809 Mar 30 11:35 AM Jain Vivek Chairman and CEO Mar 27 Option Exercise 0.00 1,933 0 82,290 Mar 30 11:31 AM McGrody Kevin J Chief Accounting Officer Mar 27 Option Exercise 0.00 647 0 2,400 Mar 30 11:27 AM Voigtlander Christian B. Chief Operating Officer Mar 06 Option Exercise 0.00 2,616 0 8,320 Mar 10 03:46 PM Woolson Daniel VP, GM-Infusion Capital Mar 06 Option Exercise 0.00 1,443 0 6,643 Mar 10 03:34 PM Jain Vivek Chairman and CEO Mar 06 Option Exercise 0.00 4,124 0 81,116 Mar 10 03:26 PM Sanzone Virginia Ruth VP, General Counsel Mar 06 Option Exercise 0.00 1,443 0 1,975 Mar 10 03:21 PM McGrody Kevin J Chief Accounting Officer Mar 06 Option Exercise 0.00 1,680 0 2,284 Mar 10 03:15 PM Bonnell Brian Michael Chief Financial Officer Mar 06 Option Exercise 0.00 722 0 722 Mar 10 02:59 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite